Tetra Bio-Pharma Inc. (TBPMQ)

OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Apr 23, 2025, 4:00 PM EDT
Market Cap 516.00
Revenue (ttm) n/a
Net Income (ttm) -29.84M
Shares Out 515.63M
EPS (ttm) -0.07
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 3,000
Open 0.0002
Previous Close 0.0002
Day's Range 0.0002 - 0.0002
52-Week Range 0.0002 - 0.0002
Beta 25.64
RSI 29.14
Earnings Date n/a

About Tetra Bio-Pharma

Tetra Bio-Pharma Inc., a biopharmaceutical company, engages in the discovery and development of cannabinoid-derived drugs for inflammation, pain, ophthalmology, and oncology. The company develops PLENITUDE to treat cancer-related pain in advanced cancer patients; REBORN for the treatment of breakthrough cancer pain; Reduvo for chemotherapy-induced nausea and vomiting; ARDS-003 for the treatment of sepsis and prevention of acute respiratory distress syndrome; and SERENITY to treat cancer cachexia. It also develops PPP003 for painful dry eye and ... [Read more]

Industry Biotechnology
Sector Healthcare
Employees 33
Stock Exchange OTCMKTS
Ticker Symbol TBPMQ
Full Company Profile

Financial Performance

Financial numbers in CAD Financial Statements

News

There is no news available yet.